TY - JOUR AU - Alifrangis, C. AU - Agarwal, R. AU - Short, D. PY - 2013 DA - 2013// TI - EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.43.1817 DO - 10.1200/JCO.2012.43.1817 ID - Alifrangis2013 ER - TY - JOUR AU - Bhala, N. AU - Coleman, J. M. AU - Radstone, C. R. PY - 2004 DA - 2004// TI - The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patients JO - Clin Oncol (R Coll Radiol) VL - 16 UR - https://doi.org/10.1016/S0936-6555(03)00166-3 DO - 10.1016/S0936-6555(03)00166-3 ID - Bhala2004 ER - TY - JOUR AU - Bosl, G. J. AU - Yagoda, A. AU - Whitmore, W. F. PY - 1984 DA - 1984// TI - VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors JO - Am J Clin Oncol VL - 7 UR - https://doi.org/10.1097/00000421-198408000-00006 DO - 10.1097/00000421-198408000-00006 ID - Bosl1984 ER - TY - JOUR AU - Bower, M. AU - Brock, C. AU - Holden, L. PY - 1997 DA - 1997// TI - POMB/ACE chemotherapy for mediastinal germ cell tumours JO - Eur J Cancer VL - 33 UR - https://doi.org/10.1016/S0959-8049(96)00403-0 DO - 10.1016/S0959-8049(96)00403-0 ID - Bower1997 ER - TY - JOUR AU - Bower, M. AU - Newlands, E. S. AU - Holden, L. PY - 1997 DA - 1997// TI - EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients JO - J Clin Oncol VL - 15 UR - https://doi.org/10.1200/JCO.1997.15.7.2636 DO - 10.1200/JCO.1997.15.7.2636 ID - Bower1997 ER - TY - JOUR AU - Cagayan, M. S. PY - 2012 DA - 2012// TI - High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy JO - J Reprod Med VL - 57 ID - Cagayan2012 ER - TY - JOUR AU - Motte Rouge, T. AU - Pautier, P. AU - Genestie, C. PY - 2016 DA - 2016// TI - Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors JO - Gynecol Oncol VL - 142 UR - https://doi.org/10.1016/j.ygyno.2016.07.005 DO - 10.1016/j.ygyno.2016.07.005 ID - Motte Rouge2016 ER - TY - JOUR AU - Feldman, D. R. AU - Lorch, A. AU - Kramar, A. PY - 2016 DA - 2016// TI - Brain metastases in patients with germ cell tumors: prognostic factors and treatment options—an analysis from the global germ cell Cancer group JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.62.7000 DO - 10.1200/JCO.2015.62.7000 ID - Feldman2016 ER - TY - BOOK PY - 2015 DA - 2015// TI - Gestational Trophoblastic Disease Regimens Gestational Trophoblastic Disease Regimens (v5.06) ID - ref9 ER - TY - BOOK PY - 2015 DA - 2015// TI - Germ Cell Tumour Regimens (v4.03) ID - ref10 ER - TY - JOUR PY - 1997 DA - 1997// TI - International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers JO - J Clin Oncol VL - 15 UR - https://doi.org/10.1200/JCO.1997.15.2.594 DO - 10.1200/JCO.1997.15.2.594 ID - ref11 ER - TY - JOUR AU - Lu, W. G. AU - Ye, F. AU - Shen, Y. M. PY - 2008 DA - 2008// TI - EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients JO - Int J Gynecol Cancer VL - 18 UR - https://doi.org/10.1111/j.1525-1438.2007.00999.x DO - 10.1111/j.1525-1438.2007.00999.x ID - Lu2008 ER - TY - JOUR AU - Lurain, J. R. AU - Brewer, J. I. AU - Mazur, M. T. PY - 1982 DA - 1982// TI - Fatal gestational trophoblastic disease: an analysis of treatment failures JO - Am J Obstet Gynecol VL - 144 UR - https://doi.org/10.1016/0002-9378(82)90242-3 DO - 10.1016/0002-9378(82)90242-3 ID - Lurain1982 ER - TY - JOUR AU - Lurain, J. R. PY - 1987 DA - 1987// TI - Causes of treatment failure in gestational trophoblastic disease JO - J Reprod Med VL - 32 ID - Lurain1987 ER - TY - JOUR AU - Lurain, J. R. AU - Singh, D. K. AU - Schink, J. C. PY - 2006 DA - 2006// TI - Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy JO - J Reprod Med VL - 51 ID - Lurain2006 ER - TY - JOUR AU - Massard, C. AU - Kramar, A. AU - Beyer, J. PY - 2013 DA - 2013// TI - Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mds504 DO - 10.1093/annonc/mds504 ID - Massard2013 ER - TY - JOUR AU - McGrath, S. AU - Short, D. AU - Harvey, R. PY - 2010 DA - 2010// TI - The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(−1) JO - Br J Cancer VL - 102 UR - https://doi.org/10.1038/sj.bjc.6605529 DO - 10.1038/sj.bjc.6605529 ID - McGrath2010 ER - TY - JOUR AU - Nur, U. AU - Rachet, B. AU - Mitry, E. PY - 2008 DA - 2008// TI - Survival from testicular cancer in England and Wales up to 2001 JO - Br J Cancer VL - 99 UR - https://doi.org/10.1038/sj.bjc.6604597 DO - 10.1038/sj.bjc.6604597 ID - Nur2008 ER - TY - JOUR AU - Oberaigner, W. AU - Minicozzi, P. AU - Bielska-Lasota, M. PY - 2012 DA - 2012// TI - Eurocare working group. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade JO - Acta Oncol VL - 51 UR - https://doi.org/10.3109/0284186X.2011.653437 DO - 10.3109/0284186X.2011.653437 ID - Oberaigner2012 ER - TY - JOUR AU - Peckham, M. J. AU - Barrett, A. AU - Liew, K. H. PY - 1983 DA - 1983// TI - The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP) JO - Br J Cancer VL - 47 UR - https://doi.org/10.1038/bjc.1983.99 DO - 10.1038/bjc.1983.99 ID - Peckham1983 ER - TY - JOUR AU - Rajpert-De, M. AU - McGlynn, K. AU - Okamoto, K. PY - 2016 DA - 2016// TI - Testicular germ cell tumours JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)00991-5 DO - 10.1016/S0140-6736(15)00991-5 ID - Rajpert-De2016 ER - TY - JOUR AU - Seckl, M. J. AU - Sebire, N. J. AU - Berkowitz, R. S. PY - 2010 DA - 2010// TI - Gestational trophoblastic disease JO - Lancet. VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60280-2 DO - 10.1016/S0140-6736(10)60280-2 ID - Seckl2010 ER -